Stop spoon dosing

You grab for the cough syrup for some relief from that nasty lingering cold, what do you measure the dose with? Many of us use teaspoons or table spoons to measure out doses for ourselves and our children but this results in dosage errors. This new study finds that errors in estimating doses can be mitigated by changing the serving measurements on the dosage facts panel from teaspoons to milliliters.

A previous study by authors Koert van Ittersum, PhD at the University of Groningen (The Netherlands) and Brian Wansink, PhD of Cornell University found that when individuals use teaspoons to measure medicine they tend to under-serve by 8.4% and when using table spoons they over-serve by 11.6%.

For this study, Van Ittersum and Wansink proposed that by writing the Drug Facts and dosage information in milliliters, which are more difficult to estimate visually, people would choose more accurate measuring devices to measure out doses and would be less likely to make dosage errors. Of the 177 young adults that participated in this study, 34.5% reported using kitchen spoons most frequently to measure medicine. The researchers found that when these study participants were given dosage information in teaspoons 60.9% chose a teaspoon to measure with while none of them chose the milliliter measuring cup. However, when the dosage recommendation was given in milliliters the teaspoon and the measuring cup were equally popular among this group. These results indicate that the risk of dosage error decreases by around 50% by simply changing the recommended units of measurement from tea spoons to milliliters.

"When measuring medicine for ourselves or our children, we often use regular kitchen spoons but they are not accurate measuring instruments," explains lead author Koert van Ittersum, "While we feel that we can estimate teaspoon doses, milliliters are much harder to estimate visually, therefore people are more likely to use accurate measuring spoons or cups when given dosage information in milliliters."

In conclusion, the authors recommend that the US Food and Drug Administration mandates that the pharmaceutical industry not use teaspoons on Drug Facts and dosing information. They also emphasize the importance of not spoon-dosing at home, instead using the measuring cups that typically come with liquid medicine.

Most Popular Now

FDA approves first biosimilar for the treatment of…

The U.S. Food and Drug Administration today approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvas...

Merck set to join forces with Project Data Sphere …

Merck, a leading science and technology company has announced that it will enter into a strategic collaboration with Project Data Sphere LLC, an independent, not-for-prof...

FDA approval brings first gene therapy to the Unit…

The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treat...

Novartis appoints Bertrand Bodson as Chief Digital…

Novartis announced today that Bertrand Bodson, Chief Digital and Marketing Officer for Sainsbury's Argos, has been appointed to the new role of Chief Digital Officer, rep...

Boehringer Ingelheim Pharmaceuticals, Inc. receive…

Boehringer Ingelheim Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved CyltezoTM, a biosimilar to Humira®*, in a pre-filled sy...

Asthma medicine halves risk of Parkinson's

Parkinson's disease is a chronic disease with unknown causes. The disease destroys the brain cells that control body movements. Shivering, stiff arms and legs and poor co...

This is how belly fat could increase your cancer r…

It's been well established that obesity is a contributor to cancer risk, but how it actually causes cancer is still a question that hasn't been fully explained. A new Mic...

Sanofi and Regeneron announce that cemiplimab (REG…

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation status to cemipli...

Tezepelumab significantly reduced asthma exacerbat…

AstraZeneca and Amgen Inc. (Amgen) announce results from the PATHWAY Phase IIb trial of tezepelumab that showed a significant reduction in the annual asthma exacerbation ...

Boehringer Ingelheim initiates Phase IIa study of …

Boehringer Ingelheim and pharmaceutical company Pharmaxis (ASX: PXS) announce that Boehringer Ingelheim has initiated a European and North American Phase IIa trial in NAS...

Extended treatment with Brilinta reduces risk of c…

AstraZeneca today announced results from a new sub-analysis of data from the Phase III PEGASUS-TIMI 54 trial demonstrating a 29% risk reduction in CV death (p=0.0041) fro...

Victoza® reduces the risk of major cardiovascular …

A new analysis of the landmark LEADER trial shows that Victoza® (liraglutide) reduced the risk of major cardiovascular (CV) events in people with type 2 diabetes at high ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]